XM does not provide services to residents of the United States of America.

IFF beats quarterly estimates on improving volume growth



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>IFF beats quarterly estimates on improving volume growth</title></head><body>

May 6 (Reuters) -Chemicals company International Flavors & Fragrances IFF.N beat market expectations for first-quarter sales and profit on Monday, helped by steady demand for its pricey product categories including scents as well as food ingredients.

Shares of the company were up about 4% in aftermarket trading.

Demand for IFF's products held as consumers stretched their budgets to shop for food ingredients to prepare more meals at home, which led to consumer goods manufacturers restocking their inventory.

Benefits from significant price hikes taken in the past quarters helped IFF in countering still-high labor and manufacturing costs.

International Flavors & Fragrances posted adjusted profit of $1.13 per share for the quarter ended March 31, compared with analysts' estimate of 87 cents per share, according to LSEG data.

The company further gained from the divestiture of its Savory Solutions and cosmetic ingredients units as well as its pharma unit, which IFF said it would sell to French plant-based ingredients maker Roquette.

The company's quarterly volumes grew mid-single digits while improving nearly across all businesses.

The company now expects annual sales to be at the high end of its prior forecast range of $10.8 billion to $11.1 billion. It also sees full-year volumes at the high end of its prior expectation of flat to 3% rise.

IFF's fiscal 2024 pricing is expected to increase about 1%, compared with its prior forecast of a decline of 2.5%.

For the first quarter, the company posted net sales of $2.90 billion, compared with analysts' average estimate of $2.78 billion.

The company also said its finance chief, Glenn Richter has planned to retire in December 31, 2024.



Reporting by Anuja Bharat Mistry in Bengaluru; Editing by Alan Barona

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.